Overview

Acute Response Capsaicin Flare Study

Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
Prior to administering PF-04427429 to patients we wish to increase the understanding of functional effects associated with calcitonin gene related peptide (CGRP) pathways. This study will examine whether it is possible for a single dose of PF-04427429 to acutely attenuate a capsaicin induced flare response.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Capsaicin
EMLA